About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Non-Invasive Liquid Biopsy Market Size, Top Share, Global Trends, Forecast to 2031
Non-Invasive Liquid Biopsy Market

Non-Invasive Liquid Biopsy Market Size, Share & Trends Analysis Report By Offering (Product, Services), By Sample (Stool, Urine, Saliva, Others), By Technology (Polymerase Chain Reaction, Sequencing, Microarray, Others), By Applications (Oncology, Reproductive Health, Metabolic Disorders, Others), By End-Users (Hospitals and Diagnostic Laboratories, Academic and Research Institutions, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI54451DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Non-Invasive Liquid Biopsy Market Introduction
    2. By Offering
      1. Introduction
        1. Offering By Value
      2. Product
        1. By Value
      3. Services
        1. By Value
    3. By Sample
      1. Introduction
        1. Sample By Value
      2. Stool
        1. By Value
      3. Urine
        1. By Value
      4. Saliva
        1. By Value
      5. Others
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Polymerase Chain Reaction
        1. By Value
      3. Sequencing
        1. By Value
      4. Microarray
        1. By Value
      5. Others
        1. By Value
    5. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Reproductive Health
        1. By Value
      4. Metabolic Disorders
        1. By Value
      5. Others
        1. By Value
    6. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Academic and Research Institutions
        1. By Value
      4. Others
        1. By Value
    1. Introduction
    2. By Offering
      1. Introduction
        1. Offering By Value
      2. Product
        1. By Value
      3. Services
        1. By Value
    3. By Sample
      1. Introduction
        1. Sample By Value
      2. Stool
        1. By Value
      3. Urine
        1. By Value
      4. Saliva
        1. By Value
      5. Others
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Polymerase Chain Reaction
        1. By Value
      3. Sequencing
        1. By Value
      4. Microarray
        1. By Value
      5. Others
        1. By Value
    5. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Reproductive Health
        1. By Value
      4. Metabolic Disorders
        1. By Value
      5. Others
        1. By Value
    6. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Academic and Research Institutions
        1. By Value
      4. Others
        1. By Value
    7. U.S.
      1. By Offering
        1. Introduction
          1. Offering By Value
        2. Product
          1. By Value
        3. Services
          1. By Value
      2. By Sample
        1. Introduction
          1. Sample By Value
        2. Stool
          1. By Value
        3. Urine
          1. By Value
        4. Saliva
          1. By Value
        5. Others
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Polymerase Chain Reaction
          1. By Value
        3. Sequencing
          1. By Value
        4. Microarray
          1. By Value
        5. Others
          1. By Value
      4. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Reproductive Health
          1. By Value
        4. Metabolic Disorders
          1. By Value
        5. Others
          1. By Value
      5. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Academic and Research Institutions
          1. By Value
        4. Others
          1. By Value
    8. Canada
    1. Introduction
    2. By Offering
      1. Introduction
        1. Offering By Value
      2. Product
        1. By Value
      3. Services
        1. By Value
    3. By Sample
      1. Introduction
        1. Sample By Value
      2. Stool
        1. By Value
      3. Urine
        1. By Value
      4. Saliva
        1. By Value
      5. Others
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Polymerase Chain Reaction
        1. By Value
      3. Sequencing
        1. By Value
      4. Microarray
        1. By Value
      5. Others
        1. By Value
    5. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Reproductive Health
        1. By Value
      4. Metabolic Disorders
        1. By Value
      5. Others
        1. By Value
    6. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Academic and Research Institutions
        1. By Value
      4. Others
        1. By Value
    7. U.K.
      1. By Offering
        1. Introduction
          1. Offering By Value
        2. Product
          1. By Value
        3. Services
          1. By Value
      2. By Sample
        1. Introduction
          1. Sample By Value
        2. Stool
          1. By Value
        3. Urine
          1. By Value
        4. Saliva
          1. By Value
        5. Others
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Polymerase Chain Reaction
          1. By Value
        3. Sequencing
          1. By Value
        4. Microarray
          1. By Value
        5. Others
          1. By Value
      4. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Reproductive Health
          1. By Value
        4. Metabolic Disorders
          1. By Value
        5. Others
          1. By Value
      5. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Academic and Research Institutions
          1. By Value
        4. Others
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. By Offering
      1. Introduction
        1. Offering By Value
      2. Product
        1. By Value
      3. Services
        1. By Value
    3. By Sample
      1. Introduction
        1. Sample By Value
      2. Stool
        1. By Value
      3. Urine
        1. By Value
      4. Saliva
        1. By Value
      5. Others
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Polymerase Chain Reaction
        1. By Value
      3. Sequencing
        1. By Value
      4. Microarray
        1. By Value
      5. Others
        1. By Value
    5. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Reproductive Health
        1. By Value
      4. Metabolic Disorders
        1. By Value
      5. Others
        1. By Value
    6. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Academic and Research Institutions
        1. By Value
      4. Others
        1. By Value
    7. China
      1. By Offering
        1. Introduction
          1. Offering By Value
        2. Product
          1. By Value
        3. Services
          1. By Value
      2. By Sample
        1. Introduction
          1. Sample By Value
        2. Stool
          1. By Value
        3. Urine
          1. By Value
        4. Saliva
          1. By Value
        5. Others
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Polymerase Chain Reaction
          1. By Value
        3. Sequencing
          1. By Value
        4. Microarray
          1. By Value
        5. Others
          1. By Value
      4. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Reproductive Health
          1. By Value
        4. Metabolic Disorders
          1. By Value
        5. Others
          1. By Value
      5. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Academic and Research Institutions
          1. By Value
        4. Others
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Offering
      1. Introduction
        1. Offering By Value
      2. Product
        1. By Value
      3. Services
        1. By Value
    3. By Sample
      1. Introduction
        1. Sample By Value
      2. Stool
        1. By Value
      3. Urine
        1. By Value
      4. Saliva
        1. By Value
      5. Others
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Polymerase Chain Reaction
        1. By Value
      3. Sequencing
        1. By Value
      4. Microarray
        1. By Value
      5. Others
        1. By Value
    5. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Reproductive Health
        1. By Value
      4. Metabolic Disorders
        1. By Value
      5. Others
        1. By Value
    6. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Academic and Research Institutions
        1. By Value
      4. Others
        1. By Value
    7. UAE
      1. By Offering
        1. Introduction
          1. Offering By Value
        2. Product
          1. By Value
        3. Services
          1. By Value
      2. By Sample
        1. Introduction
          1. Sample By Value
        2. Stool
          1. By Value
        3. Urine
          1. By Value
        4. Saliva
          1. By Value
        5. Others
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Polymerase Chain Reaction
          1. By Value
        3. Sequencing
          1. By Value
        4. Microarray
          1. By Value
        5. Others
          1. By Value
      4. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Reproductive Health
          1. By Value
        4. Metabolic Disorders
          1. By Value
        5. Others
          1. By Value
      5. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Academic and Research Institutions
          1. By Value
        4. Others
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. By Offering
      1. Introduction
        1. Offering By Value
      2. Product
        1. By Value
      3. Services
        1. By Value
    3. By Sample
      1. Introduction
        1. Sample By Value
      2. Stool
        1. By Value
      3. Urine
        1. By Value
      4. Saliva
        1. By Value
      5. Others
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Polymerase Chain Reaction
        1. By Value
      3. Sequencing
        1. By Value
      4. Microarray
        1. By Value
      5. Others
        1. By Value
    5. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Reproductive Health
        1. By Value
      4. Metabolic Disorders
        1. By Value
      5. Others
        1. By Value
    6. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Academic and Research Institutions
        1. By Value
      4. Others
        1. By Value
    7. Brazil
      1. By Offering
        1. Introduction
          1. Offering By Value
        2. Product
          1. By Value
        3. Services
          1. By Value
      2. By Sample
        1. Introduction
          1. Sample By Value
        2. Stool
          1. By Value
        3. Urine
          1. By Value
        4. Saliva
          1. By Value
        5. Others
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Polymerase Chain Reaction
          1. By Value
        3. Sequencing
          1. By Value
        4. Microarray
          1. By Value
        5. Others
          1. By Value
      4. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Reproductive Health
          1. By Value
        4. Metabolic Disorders
          1. By Value
        5. Others
          1. By Value
      5. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Academic and Research Institutions
          1. By Value
        4. Others
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. Non-Invasive Liquid Biopsy Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Bio-Techne Corporation
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Exact Sciences Corporation
    3. Thermo Fisher Scientific Inc.
    4. QIAGEN N.V.
    5. MDxHealth
    6. Lonza Group AG
    7. PerkinElmer Inc.
    8. Merck KGaA
    9. OraSure Technologies Inc.
    10. Norgen Biotek Corp
    11. Zymo Research Corporation
    12. Oasis Diagnostics Corporation
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Bispecific Antibodies Market Size The global bispecific antibodies market size was valued at USD 11.84 billion in 2024 and is expected to grow from USD 17.10 billion in 2025 to USD 323.21 billion by 2033, growing at a CAGR of 44.4% du
Buy Now
Global Report
X-Ray Inspection System Market Size The global x-ray inspection system market size was valued at USD 834.65 million in 2024 and is expected to grow from USD 889.74 million in 2025 to reach USD 1483.61 million by 2033, growin
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.